Treatonic Hemorrhoid Treatment Cream
NDC Package 85569-008-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Treatonic Hemorrhoid Treatment (5% lidocaine) cream is adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. This formulation utilizes a cream delivery system. Marketed by 100 Karma Inc, this product is identified by NDC 85569-008 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
85569-008-01
Package Description
50 g in 1 CARTON
Product Code
85569-008
11-Digit Billing Format
85569000801
RxNorm Crosswalk
  • RxCUI: 1314136 - lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Cream
  • RxCUI: 1314136 - lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream
  • RxCUI: 1314136 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Cream

Clinical Specifications

Proprietary Name
Treatonic Hemorrhoid Treatment
Non-Proprietary Name
5% Lidocaine
Substance Name
Lidocaine; Phenylephrine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. Children under 12 years of age: consult a doctor.For External use: Apply externally to the affected area up to 4 times daily.For Intrarectal use: Attach applicator to tube. Lubricate applicator well, then gently insert applicator into the rectum. Apply to the affected area up to 4 times daily.

Regulatory & Marketing

Labeler Name
100 Karma Inc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-31-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85569-008-01 identifies a specific commercial package of 50 g in 1 carton of Treatonic Hemorrhoid Treatment, a human over the counter drug labeled by 100 Karma Inc. This cream is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by 100 Karma Inc on October 31, 2025. The current certification is valid through December 31, 2026.

How is this 100 Karma Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85569000801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85569-008-01
11-Digit CMS (5-4-2)
85569-0008-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.